查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
2010035

支架市场：2026-2032年全球市场预测（依产品类型、材料、输送方式、应用及最终用户划分）

Stents Market by Product Type, Material, Mode of Delivery, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，支架市场价值将达到 150.1 亿美元，到 2026 年将成长到 161.1 亿美元，到 2032 年将达到 253.3 亿美元，复合年增长率为 7.75%。

主要市场统计数据
基准年 2025 150.1亿美元
预计年份：2026年 161.1亿美元
预测年份 2032 253.3亿美元
复合年增长率 (%) 7.75%

简要概述临床创新、监管要求和医疗保健服务体系的变化如何重塑支架和介入器材的策略。

支架领域在介入医学、器材工程和医疗保健系统经济学的交叉领域中发挥着至关重要的作用。材料科学、手术流程和影像技术的进步，已将支架的治疗应用范围从冠状动脉介入扩展到神经血管、週边血管、胃肠道和泌尿系统等领域。临床医生越来越倾向于选择微创治疗方案，因为这些方案可以缩短恢復时间、降低併发症率，并有可能实现门诊治疗，从而导致采购重点和医疗服务模式的重组。

材料创新、设计进步和商业平台策略如何推动支架开发和临床应用的模式转移。

支架产业正经历一场变革性的转型，这主要得益于技术、监管和医疗服务三者之间的协同作用。随着製造商从传统的不銹钢结构转向采用更先进的合金和聚合物技术，以提升柔软性、渗透性和生物相容性，材料创新正在重新定义器材的性能。这些材料的进步使得支架的输送系统更加低矮，植入更加精准，从而能够更好地适应解剖结构复杂的适应症和复杂的患者群体。

评估近期关税政策的变化如何重塑整个医疗保健系统的支架供应链、製造地和商业性采购趋势。

美国2025年实施的新关税政策正促使支架生态系统重新评估其全球製造、采购和定价策略。先前以成本和规模为优化目标的供应链，如今正因进口关税对零件和成品经济效益的影响而接受重新审视。这些关税压力正在加速供应商多元化，并重新激发人们对本地製造的兴趣，以降低跨境贸易波动风险。

深入了解产品系列、材料选择、交付系统、临床用例和医疗保健环境如何相互交织，从而影响技术采用和商业策略。

细分市场层面的趋势揭示了不同产品类型、材料、交付方式、临床应用和终端使用者环境的需求驱动因素和明确的策略重点。产品种类繁多，涵盖了从专注于心肌再灌注的冠状动脉支架到旨在缓解管腔阻塞的胃肠道器械，再到用于颈动脉和颅内应用的消化器官系统支架、用于颈动脉、股动脉、髂动脉和肾动脉疾病的外周支架，甚至包括针对前列腺和输尿管适应症的泌尿系统支架。每个产品组都有其独特的操作要求、监管考虑和临床医生培训需求，这些因素都会影响部署计划和临床路径。

影响美洲、欧洲、中东、非洲和亚太地区监管预期、临床引入模式和生产策略的区域趋势。

区域趋势正在影响美洲、欧洲、中东和非洲以及亚太地区的创新轨迹、监管要求和医疗服务提供者的采购惯例。在美洲，临床医生在微创介入心臟病学的熟练程度以及主要医疗设备製造商的集中，支持了快速的临床应用和产品的迭代改进。法律规范强调可靠的临床数据和上市后监测，这指导产品开发朝着长期疗效证据和性能一致性的方向发展。

在支架领域，成熟企业、创新专家和策略伙伴关係如何汇聚一堂，重新定义竞争定位和长期差异化？

支架产业的竞争动态反映了成熟製造商（拥有广泛的产品系列）与新兴专业厂商（引领利基技术）之间的平衡。领先的医疗设备公司持续投资于核心平台的迭代改进，同时透过收购、共同开发契约和销售伙伴关係等方式拓展邻近领域。这些措施旨在拓宽临床适应症、加速监管核准，并整合先进影像技术和输送系统等互补技术。

为製造商和相关人员提供切实可行的策略建议，以增强支架产业的供应链韧性、临床差异化和商业性价值创造。

产业领导企业应优先考虑多管齐下的策略，将创新、价值链韧性和相关人员价值结合。首先，多元化采购和投资柔性製造平台将有助于降低贸易中断带来的风险，并随着市场普及速度的加速而支持快速规模化发展。将部分业务外包到近岸地区，并与契约製造製造商建立策略伙伴关係，可以在保持成本竞争力的同时，提高前置作业时间的可靠性。

采用透明且可重复的调查方法，结合对临床医生的访谈、对监管和科学文献的审查以及可靠的检验，以检验研究结果。

本研究途径结合了结构化的初步研究、系统性的二次文献回顾和严谨的检验，以确保研究结果的可靠性和有效性。初步研究包括对介入临床医生、采购经理、监管专家和器材工程师进行详细访谈，以识别实际临床挑战、推动器材应用和未满足的临床需求。这些访谈提供了不同医疗机构中手术流程、器械选择标准和操作限制等方面的背景资讯。

对临床证据、製造灵活性和生态系统协作如何决定不断发展的支架市场中的竞争赢家进行综合分析。

支架技术和商业化正进入以临床疗效、营运可行性和供应链韧性主导的「可操作创新」阶段。材料和输送系统的进步正在拓展血管、神经血管、胃肠道和泌尿系统领域的治疗可能性，同时监管和报销环境也正将重点转向长期疗效和可验证的价值。医疗服务提供者和保险公司越来越重视产品的持久性和成本效益，这凸显了整合资料策略和以结果主导的产品定位的重要性。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：支架市场：依产品类型划分

  • 冠状动脉支架
  • 胃肠道支架
  • 神经血管支架
    • 颅外颈动脉支架
    • 颅内支架
  • 外周支架
    • 颈动脉支架
    • 股动脉支架
    • 髂动脉支架
    • 肾动脉支架
  • 泌尿系统支架
    • 摄护腺支架
    • 输尿管支架

第九章：支架市场：依材料分类

  • 金属支架
    • 钴铬合金
    • 镍钛诺
    • 铂金铬
    • 不銹钢
  • 聚合物支架
    • 可生物降解聚合物
    • 不可生物降解聚合物

第十章：支架市场依输送方式划分

  • 球囊扩张型支架
  • 自动扩张型支架

第十一章：支架市场：依应用领域划分

  • 心血管疾病
  • 胃肠道阻塞
  • 神经血管疾病
  • 肿瘤相关应用
  • 周边动脉疾病（PAD）
  • 泌尿系统疾病

第十二章：支架市场：依最终用户划分

  • 门诊手术中心（ASC）
  • 循环系统中心
  • 医院
  • 专科诊所

第十三章：支架市场：按地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章：支架市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 支架市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章：美国支架市场

第十七章：中国支架市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • BIOTRONIK SE & Co. KG
  • Boston Scientific Corporation
  • Cook Medical LLC
  • Cordis Corporation
  • Elixir Medical Corporation
  • Endologix LLC
  • InspireMD, Inc.
  • Lepu Medical Technology Co., Ltd
  • Medinol Ltd.
  • Medtronic plc
  • Meril Life Sciences Pvt. Ltd
  • MicroPort Scientific Corporation
  • Sahajanand Medical Technologies Pvt. Ltd
  • Shanghai MicroPort Medical（Group）Co., Ltd
  • STENTYS SA
  • Terumo Corporation
  • WL Gore & Associates, Inc.
Product Code: MRR-434CCDA04EF3

The Stents Market was valued at USD 15.01 billion in 2025 and is projected to grow to USD 16.11 billion in 2026, with a CAGR of 7.75%, reaching USD 25.33 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 15.01 billion
Estimated Year [2026] USD 16.11 billion
Forecast Year [2032] USD 25.33 billion
CAGR (%) 7.75%

A concise strategic overview of how clinical innovation, regulatory demands, and care delivery shifts are reshaping stents and interventional device strategies

The stents landscape occupies a pivotal role at the intersection of interventional medicine, device engineering, and health system economics. Advances in materials science, procedural techniques, and imaging technologies have broadened the therapeutic applications of stents beyond coronary interventions to encompass neurovascular, peripheral, gastrointestinal, and urological contexts. Clinicians increasingly favor minimally invasive options that shorten recovery, lower complication rates, and enable outpatient pathways, which in turn reshapes procurement priorities and care delivery models.

Industry participants operate within a complex regulatory and reimbursement environment that demands rigorous clinical evidence and post-market surveillance. Regulatory pathways now emphasize long-term safety and real-world performance, prompting manufacturers to integrate data generation into product strategies. Concurrently, provider systems are exploring value-based contracting and outcome-linked procurement, which raises the bar for comparative clinical benefit and cost-effectiveness.

This report synthesizes technological, clinical, and commercial signals to outline where innovation is creating differentiated value and where operational pressures are prompting strategic realignment. It intends to provide leaders with a clear baseline of contemporary dynamics, enabling them to prioritize investment, optimize supply chains, and refine go-to-market approaches in response to evolving stakeholder expectations.

How materials breakthroughs, design evolution, and commercial platform strategies are driving a paradigm shift in stents development and clinical adoption

The stents landscape is experiencing transformative shifts driven by converging forces across technology, regulation, and healthcare delivery. Materials innovation is redefining device performance as manufacturers move from traditional stainless steel constructs toward advanced alloys and polymer technologies that offer improved flexibility, radiopacity, and biological compatibility. These material advances enable lower-profile delivery systems and more precise deployment, which supports expansion into anatomically challenging indications and complex patient cohorts.

Concurrently, device design is aligning more closely with physiologic preservation and restenosis mitigation. Drug-eluting coatings, bioresorbable scaffolds, and surface engineering techniques aim to minimize neointimal proliferation while preserving vessel integrity. These design trends are complemented by improvements in imaging and navigation tools, which facilitate highly targeted interventions and reduce procedural variability. The interplay between device performance and procedural precision has important implications for training, procedural guidelines, and clinical adoption.

On the commercial front, consolidation among suppliers and strategic partnerships with technology firms are accelerating platform-based approaches that combine hardware with data-driven services. Reimbursement models are shifting toward value recognition, encouraging manufacturers to demonstrate long-term outcomes rather than focusing solely on peri-procedural metrics. At the same time, the provider landscape is decentralizing with greater adoption of ambulatory surgical centers and specialty clinics for selected procedures, prompting manufacturers to develop simplified systems and service models that support outpatient workflows.

Regulatory authorities are reinforcing post-market evidence requirements and real-world data collection, which increases the need for integrated registries and longitudinal follow-up. In response, manufacturers are investing in data infrastructure, remote monitoring, and stakeholder engagement strategies. In short, the industry is transitioning from single-product innovation toward integrated solutions that combine materials, procedural systems, data, and service models to deliver demonstrable clinical and economic value.

Assessment of how recent tariff policy changes are reshaping stents supply chains, manufacturing footprints, and commercial procurement dynamics across healthcare systems

The introduction of new tariff policies in the United States in 2025 has prompted a reassessment of global manufacturing, sourcing, and pricing strategies within the stents ecosystem. Supply chains that were previously optimized for cost and scale are experiencing renewed scrutiny as import levies affect component and finished-device economics. These tariff pressures have accelerated diversification of supplier bases and reignited interest in regional manufacturing to reduce exposure to cross-border trade volatility.

Manufacturers with vertically integrated capabilities or flexible production footprints have found it easier to adapt, while firms reliant on specialized overseas component suppliers have faced increased input cost volatility. In response, many companies are negotiating longer-term agreements, relocating certain manufacturing steps closer to end markets, and exploring toll-manufacturing arrangements to spread fixed costs and maintain continuity of supply. These operational moves are altering capital allocation decisions and influencing where R&D investments are directed.

Procurement teams within hospitals and health systems have also adjusted sourcing strategies to mitigate pass-through cost increases. Some providers have recalibrated device selection protocols and engaged in tighter contract negotiations, while others have pursued group purchasing arrangements to preserve access to preferred technologies. Payers and health technology assessors have been attentive to any implications for total procedure cost and long-term outcomes, which has amplified the need for transparency in pricing and demonstrated value propositions.

Importantly, the tariff environment has created an incentive for domestic and nearshore manufacturing investment, supporting policy conversations around medical device sovereignty and supply chain resilience. At the same time, the heightened cost environment may spur incremental innovation focused on materials efficiency, modular manufacturing, and reusable tooling. Overall, the cumulative impact of tariff changes is less a one-time shock and more a catalyst for structural shifts in sourcing, manufacturing strategy, and commercial engagement across the stents sector.

Insights into how product families, material choices, delivery systems, clinical use cases, and care settings collectively shape technology adoption and commercial strategy

Segment-level dynamics reveal differentiated demand drivers and distinct strategic priorities across product categories, materials, delivery modes, clinical applications, and end-user settings. Product diversity ranges from coronary stents focused on myocardial revascularization to gastrointestinal devices aimed at relieving luminal obstruction, neurovascular stents designed for carotid and intracranial applications, peripheral stents that address carotid, femoral, iliac, and renal arterial disease, as well as urological stents tailored to prostatic and ureteral indications. Each product family carries unique procedural requirements, regulatory considerations, and clinician training needs, which influences adoption timelines and clinical pathways.

Material choice exerts a foundational influence on device behavior, with metallic stents constructed from alloys such as cobalt chromium, nitinol, platinum chromium, and stainless steel delivering established radial strength and fatigue resistance for demanding vascular territories. Polymeric alternatives, including biodegradable and non-biodegradable polymer compositions, present opportunities for temporary scaffolding that could reduce long-term implant burden and facilitate future interventions. Material innovations also intersect with coating strategies and drug-elution technologies, shaping healing responses and long-term vessel patency profiles.

Mode of delivery is a central determinant of clinical use cases and procedure setting, with balloon-expandable systems traditionally used where precise deployment and high radial force are required, while self-expanding platforms offer conformability in tortuous or dynamic vascular segments. These differences impact device sizing algorithms, imaging requirements, and operator learning curves. Clinical application areas span cardiovascular disease leading to coronary interventions, gastrointestinal obstructions that require luminal patency restoration, neurovascular conditions demanding delicate intracranial navigation, oncology-related uses where stents support tumor-related obstruction management, peripheral artery disease where limb salvage and symptom alleviation are priorities, and urological disorders focusing on urinary drainage and obstruction relief.

End-user environments further modulate product requirements and commercial approaches. Ambulatory surgical centers and specialty clinics increasingly demand devices that enable shorter procedure times, simplified logistics, and predictable recovery, whereas hospitals and cardiology centers prioritize comprehensive product portfolios, integration with complex imaging suites, and robust support for high-acuity cases. Understanding how each segmentation axis interacts is essential for tailoring clinical evidence generation, training programs, and commercial models that align with specific stakeholder needs.

Regional dynamics affecting regulatory expectations, clinical adoption patterns, and manufacturing strategies across the Americas, Europe Middle East & Africa, and Asia-Pacific

Geographic dynamics influence innovation trajectories, regulatory requirements, and provider procurement practices across the Americas, Europe Middle East & Africa, and Asia-Pacific regions. In the Americas, clinician familiarity with minimally invasive cardiovascular interventions and a concentrated base of leading device manufacturers supports rapid clinical adoption and iterative product improvement. Regulatory frameworks emphasize robust clinical data and post-market surveillance, which steers product development toward long-term outcome evidence and performance consistency.

In Europe, the Middle East, and Africa, regulatory harmonization efforts coexist with regional variations that affect time-to-market and local clinical practice patterns. Several markets within this broad region demonstrate strong clinical research networks and advanced interventional capabilities, while others are focused on expanding access and building procedural capacity. Providers in this region often balance cost considerations with the desire for proven clinical benefit, shaping procurement strategies and local distributor models.

The Asia-Pacific landscape is characterized by diverse healthcare systems, rapidly expanding interventional capability in key markets, and an active manufacturing ecosystem that supplies both regional and global demand. Innovation hubs in this region are contributing to device engineering advances and high-volume, cost-sensitive production. More broadly, each region presents distinct opportunities for clinical partnerships, localized manufacturing investments, and tailored go-to-market approaches that reflect reimbursement structures, provider capabilities, and patient demographics.

How incumbent firms, specialized innovators, and strategic partnerships are converging to redefine competitive positioning and long term differentiation in stents

Competitive dynamics in the stents arena reflect a balance between entrenched manufacturers with broad portfolios and emerging specialists advancing niche technologies. Leading device companies continue to invest in iterative improvements to core platforms while seeking adjacent expansion through acquisitions, co-development agreements, and distribution partnerships. These efforts aim to broaden clinical indications, accelerate regulatory approvals, and integrate complementary technologies such as advanced imaging and delivery systems.

Smaller and mid-sized innovators often focus on specialized materials, novel drug-eluting chemistries, or unique delivery mechanisms that address unmet clinical needs or simplify procedures. Strategic collaborations between incumbents and innovators are increasingly common, enabling rapid scale-up of promising technologies and shared access to clinical trial networks. In parallel, contract manufacturers and component suppliers play a critical role in enabling speed-to-market and flexible production, especially as firms respond to supply chain pressures.

Commercial differentiation increasingly depends on demonstrating longitudinal patient benefits and offering service-oriented solutions such as training programs, registry support, and performance analytics. Companies that successfully combine clinical excellence with operational support and transparent value communication tend to gain preferential positioning with large provider systems. Continued M&A activity, selective partnership models, and investments in post-market evidence generation will shape competitive positioning in the near term.

Practical strategic prescriptions for manufacturers and stakeholders to strengthen supply resilience, clinical differentiation, and commercial value capture in stents

Industry leaders should prioritize a multi-dimensional strategy that aligns innovation with supply chain resilience and stakeholder value. First, investing in diversified sourcing and flexible manufacturing platforms reduces exposure to trade disruptions and supports rapid scaling when adoption accelerates. Nearshoring selected operations and developing strategic partnerships with contract manufacturers can preserve cost competitiveness while improving lead-time reliability.

Second, accelerating materials and coating research that demonstrably improves long-term clinical outcomes will be critical to securing favorable procurement positioning. Demonstrations of reduced restenosis, lower complication rates, and simplified reintervention pathways will resonate with payers and large provider systems. Integrating robust real-world data collection and registries into product launches will support these claims and facilitate value-based contracting discussions.

Third, tailor commercial approaches to end-user environments by designing devices and service models that meet the specific needs of ambulatory surgical centers, specialty clinics, and high-acuity hospitals. Simplified systems that reduce procedure time and logistics burden are likely to find traction in outpatient settings, while comprehensive portfolio support and integration with imaging ecosystems will be essential for tertiary centers.

Fourth, proactively address regulatory and reimbursement evolution by engaging early with authorities, aligning clinical programs to long-term performance endpoints, and preparing transparent pricing models that articulate total cost of care benefits. Finally, cultivate partnerships across the ecosystem - including imaging firms, digital health providers, and academic centers - to build platform solutions that combine hardware with data and services, thereby creating defensible differentiation and stronger commercial value propositions.

A transparent and reproducible methodology combining clinician interviews, regulatory and scientific literature review, and robust triangulation to validate insights

The research approach combined structured primary inquiry, systematic secondary review, and rigorous triangulation to ensure reliability and relevance. Primary research consisted of in-depth interviews with interventional clinicians, procurement leaders, regulatory experts, and device engineers to surface real-world challenges, adoption drivers, and unmet clinical needs. These conversations provided context on procedural workflows, device preferences, and the operational constraints of different care settings.

Secondary research included peer-reviewed literature, regulatory guidance documents, clinical trial registries, and company disclosures to map technological trends, material science developments, and competitive activities. Publicly available regulatory filings and guidance informed the assessment of evidence expectations and approval pathways. The integration of these sources enabled identification of convergent signals and informed scenario analysis around supply chain and commercial impacts.

Data synthesis involved cross-validation between interview insights and documentary evidence, followed by qualitative coding to extract thematic patterns across product segments, materials, delivery systems, clinical applications, and geographic regions. The methodology emphasized transparency and reproducibility, with key assumptions and limitations explicitly documented. Stakeholder validation sessions were conducted to refine findings and ensure practical applicability for commercial and clinical decision-makers.

Synthesis of how clinical evidence, manufacturing agility, and ecosystem collaboration will determine competitive winners in the evolving stents landscape

Stents technology and commercialization are entering a phase of pragmatic innovation where clinical efficacy, operational feasibility, and supply chain resilience will determine leadership. Advances in materials and delivery systems are expanding therapeutic possibilities across vascular, neurovascular, gastrointestinal, and urological domains, while regulatory and reimbursement environments are shifting focus toward long-term outcomes and demonstrable value. Providers and payers increasingly expect evidence of durability and cost-efficiency, which places a premium on integrated data strategies and outcome-driven product positioning.

The cumulative effect of recent trade policy shifts and changing provider care models underscores the importance of adaptive manufacturing strategies and targeted commercial approaches. Firms that align technical innovation with resilient operations and clear value articulation will be best positioned to capture momentum. Collaboration across the ecosystem - from imaging partners to academic networks and payers - will accelerate adoption and support the shift toward platform-based solutions that combine devices with data and services.

Overall, the period ahead favors organizations that combine rigorous clinical evidence, agile manufacturing, and customer-centric commercial models to deliver measurable improvements in patient outcomes and provider efficiency. Those who act decisively to integrate these elements into cohesive strategies will create enduring competitive advantage.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Stents Market, by Product Type

  • 8.1. Coronary Stents
  • 8.2. Gastrointestinal Stents
  • 8.3. Neurovascular Stents
    • 8.3.1. Extracranial Carotid Artery Stents
    • 8.3.2. Intracranial Stents
  • 8.4. Peripheral Stents
    • 8.4.1. Carotid Artery Stents
    • 8.4.2. Femoral Artery Stents
    • 8.4.3. Iliac Artery Stents
    • 8.4.4. Renal Artery Stents
  • 8.5. Urological Stents
    • 8.5.1. Prostatic Stents
    • 8.5.2. Ureteral Stents

9. Stents Market, by Material

  • 9.1. Metallic Stents
    • 9.1.1. Cobalt Chromium
    • 9.1.2. Nitinol
    • 9.1.3. Platinum Chromium
    • 9.1.4. Stainless Steel
  • 9.2. Polymeric Stents
    • 9.2.1. Biodegradable Polymers
    • 9.2.2. Non-biodegradable Polymers

10. Stents Market, by Mode of Delivery

  • 10.1. Balloon-Expandable Stents
  • 10.2. Self-Expanding Stents

11. Stents Market, by Application

  • 11.1. Cardiovascular Diseases
  • 11.2. Gastrointestinal Obstructions
  • 11.3. Neurovascular Conditions
  • 11.4. Oncology-Related Applications
  • 11.5. Peripheral Artery Disease (PAD)
  • 11.6. Urological Disorders

12. Stents Market, by End User

  • 12.1. Ambulatory Surgical Centers (ASCs)
  • 12.2. Cardiology Centers
  • 12.3. Hospitals
  • 12.4. Specialty Clinics

13. Stents Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Stents Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Stents Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Stents Market

17. China Stents Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Abbott Laboratories
  • 18.6. B. Braun Melsungen AG
  • 18.7. Becton, Dickinson and Company
  • 18.8. BIOTRONIK SE & Co. KG
  • 18.9. Boston Scientific Corporation
  • 18.10. Cook Medical LLC
  • 18.11. Cordis Corporation
  • 18.12. Elixir Medical Corporation
  • 18.13. Endologix LLC
  • 18.14. InspireMD, Inc.
  • 18.15. Lepu Medical Technology Co., Ltd
  • 18.16. Medinol Ltd.
  • 18.17. Medtronic plc
  • 18.18. Meril Life Sciences Pvt. Ltd
  • 18.19. MicroPort Scientific Corporation
  • 18.20. Sahajanand Medical Technologies Pvt. Ltd
  • 18.21. Shanghai MicroPort Medical (Group) Co., Ltd
  • 18.22. STENTYS SA
  • 18.23. Terumo Corporation
  • 18.24. W. L. Gore & Associates, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL STENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL STENTS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL STENTS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL STENTS MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL STENTS MARKET SIZE, BY MODE OF DELIVERY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL STENTS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL STENTS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL STENTS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL STENTS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL STENTS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES STENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA STENTS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL STENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL STENTS MARKET SIZE, BY CORONARY STENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL STENTS MARKET SIZE, BY CORONARY STENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL STENTS MARKET SIZE, BY CORONARY STENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL STENTS MARKET SIZE, BY GASTROINTESTINAL STENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL STENTS MARKET SIZE, BY GASTROINTESTINAL STENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL STENTS MARKET SIZE, BY GASTROINTESTINAL STENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL STENTS MARKET SIZE, BY NEUROVASCULAR STENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL STENTS MARKET SIZE, BY NEUROVASCULAR STENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL STENTS MARKET SIZE, BY NEUROVASCULAR STENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL STENTS MARKET SIZE, BY NEUROVASCULAR STENTS, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL STENTS MARKET SIZE, BY EXTRACRANIAL CAROTID ARTERY STENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL STENTS MARKET SIZE, BY EXTRACRANIAL CAROTID ARTERY STENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL STENTS MARKET SIZE, BY EXTRACRANIAL CAROTID ARTERY STENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL STENTS MARKET SIZE, BY INTRACRANIAL STENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL STENTS MARKET SIZE, BY INTRACRANIAL STENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL STENTS MARKET SIZE, BY INTRACRANIAL STENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL STENTS MARKET SIZE, BY PERIPHERAL STENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL STENTS MARKET SIZE, BY PERIPHERAL STENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL STENTS MARKET SIZE, BY PERIPHERAL STENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL STENTS MARKET SIZE, BY PERIPHERAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL STENTS MARKET SIZE, BY CAROTID ARTERY STENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL STENTS MARKET SIZE, BY CAROTID ARTERY STENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL STENTS MARKET SIZE, BY CAROTID ARTERY STENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL STENTS MARKET SIZE, BY FEMORAL ARTERY STENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL STENTS MARKET SIZE, BY FEMORAL ARTERY STENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL STENTS MARKET SIZE, BY FEMORAL ARTERY STENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL STENTS MARKET SIZE, BY ILIAC ARTERY STENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL STENTS MARKET SIZE, BY ILIAC ARTERY STENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL STENTS MARKET SIZE, BY ILIAC ARTERY STENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL STENTS MARKET SIZE, BY RENAL ARTERY STENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL STENTS MARKET SIZE, BY RENAL ARTERY STENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL STENTS MARKET SIZE, BY RENAL ARTERY STENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL STENTS MARKET SIZE, BY UROLOGICAL STENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL STENTS MARKET SIZE, BY UROLOGICAL STENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL STENTS MARKET SIZE, BY UROLOGICAL STENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL STENTS MARKET SIZE, BY UROLOGICAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL STENTS MARKET SIZE, BY PROSTATIC STENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL STENTS MARKET SIZE, BY PROSTATIC STENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL STENTS MARKET SIZE, BY PROSTATIC STENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL STENTS MARKET SIZE, BY URETERAL STENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL STENTS MARKET SIZE, BY URETERAL STENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL STENTS MARKET SIZE, BY URETERAL STENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL STENTS MARKET SIZE, BY METALLIC STENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL STENTS MARKET SIZE, BY METALLIC STENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL STENTS MARKET SIZE, BY METALLIC STENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL STENTS MARKET SIZE, BY METALLIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL STENTS MARKET SIZE, BY COBALT CHROMIUM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL STENTS MARKET SIZE, BY COBALT CHROMIUM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL STENTS MARKET SIZE, BY COBALT CHROMIUM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL STENTS MARKET SIZE, BY NITINOL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL STENTS MARKET SIZE, BY NITINOL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL STENTS MARKET SIZE, BY NITINOL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL STENTS MARKET SIZE, BY PLATINUM CHROMIUM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL STENTS MARKET SIZE, BY PLATINUM CHROMIUM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL STENTS MARKET SIZE, BY PLATINUM CHROMIUM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL STENTS MARKET SIZE, BY STAINLESS STEEL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL STENTS MARKET SIZE, BY STAINLESS STEEL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL STENTS MARKET SIZE, BY STAINLESS STEEL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL STENTS MARKET SIZE, BY POLYMERIC STENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL STENTS MARKET SIZE, BY POLYMERIC STENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL STENTS MARKET SIZE, BY POLYMERIC STENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL STENTS MARKET SIZE, BY POLYMERIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL STENTS MARKET SIZE, BY BIODEGRADABLE POLYMERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL STENTS MARKET SIZE, BY BIODEGRADABLE POLYMERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL STENTS MARKET SIZE, BY BIODEGRADABLE POLYMERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL STENTS MARKET SIZE, BY NON-BIODEGRADABLE POLYMERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL STENTS MARKET SIZE, BY NON-BIODEGRADABLE POLYMERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL STENTS MARKET SIZE, BY NON-BIODEGRADABLE POLYMERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL STENTS MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL STENTS MARKET SIZE, BY BALLOON-EXPANDABLE STENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL STENTS MARKET SIZE, BY BALLOON-EXPANDABLE STENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL STENTS MARKET SIZE, BY BALLOON-EXPANDABLE STENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL STENTS MARKET SIZE, BY SELF-EXPANDING STENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL STENTS MARKET SIZE, BY SELF-EXPANDING STENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL STENTS MARKET SIZE, BY SELF-EXPANDING STENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL STENTS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL STENTS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL STENTS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL STENTS MARKET SIZE, BY GASTROINTESTINAL OBSTRUCTIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL STENTS MARKET SIZE, BY GASTROINTESTINAL OBSTRUCTIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL STENTS MARKET SIZE, BY GASTROINTESTINAL OBSTRUCTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL STENTS MARKET SIZE, BY NEUROVASCULAR CONDITIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL STENTS MARKET SIZE, BY NEUROVASCULAR CONDITIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL STENTS MARKET SIZE, BY NEUROVASCULAR CONDITIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL STENTS MARKET SIZE, BY ONCOLOGY-RELATED APPLICATIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL STENTS MARKET SIZE, BY ONCOLOGY-RELATED APPLICATIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL STENTS MARKET SIZE, BY ONCOLOGY-RELATED APPLICATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL STENTS MARKET SIZE, BY PERIPHERAL ARTERY DISEASE (PAD), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL STENTS MARKET SIZE, BY PERIPHERAL ARTERY DISEASE (PAD), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL STENTS MARKET SIZE, BY PERIPHERAL ARTERY DISEASE (PAD), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL STENTS MARKET SIZE, BY UROLOGICAL DISORDERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL STENTS MARKET SIZE, BY UROLOGICAL DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL STENTS MARKET SIZE, BY UROLOGICAL DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS (ASCS), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS (ASCS), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS (ASCS), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL STENTS MARKET SIZE, BY CARDIOLOGY CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL STENTS MARKET SIZE, BY CARDIOLOGY CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL STENTS MARKET SIZE, BY CARDIOLOGY CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL STENTS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL STENTS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL STENTS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL STENTS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL STENTS MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL STENTS MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL STENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 112. AMERICAS STENTS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 113. AMERICAS STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 114. AMERICAS STENTS MARKET SIZE, BY NEUROVASCULAR STENTS, 2018-2032 (USD MILLION)
  • TABLE 115. AMERICAS STENTS MARKET SIZE, BY PERIPHERAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 116. AMERICAS STENTS MARKET SIZE, BY UROLOGICAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 117. AMERICAS STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 118. AMERICAS STENTS MARKET SIZE, BY METALLIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 119. AMERICAS STENTS MARKET SIZE, BY POLYMERIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 120. AMERICAS STENTS MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 121. AMERICAS STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 122. AMERICAS STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 123. NORTH AMERICA STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. NORTH AMERICA STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 125. NORTH AMERICA STENTS MARKET SIZE, BY NEUROVASCULAR STENTS, 2018-2032 (USD MILLION)
  • TABLE 126. NORTH AMERICA STENTS MARKET SIZE, BY PERIPHERAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 127. NORTH AMERICA STENTS MARKET SIZE, BY UROLOGICAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 128. NORTH AMERICA STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 129. NORTH AMERICA STENTS MARKET SIZE, BY METALLIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 130. NORTH AMERICA STENTS MARKET SIZE, BY POLYMERIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 131. NORTH AMERICA STENTS MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 132. NORTH AMERICA STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 133. NORTH AMERICA STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 134. LATIN AMERICA STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. LATIN AMERICA STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. LATIN AMERICA STENTS MARKET SIZE, BY NEUROVASCULAR STENTS, 2018-2032 (USD MILLION)
  • TABLE 137. LATIN AMERICA STENTS MARKET SIZE, BY PERIPHERAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 138. LATIN AMERICA STENTS MARKET SIZE, BY UROLOGICAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 139. LATIN AMERICA STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 140. LATIN AMERICA STENTS MARKET SIZE, BY METALLIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 141. LATIN AMERICA STENTS MARKET SIZE, BY POLYMERIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 142. LATIN AMERICA STENTS MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 143. LATIN AMERICA STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 144. LATIN AMERICA STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE, MIDDLE EAST & AFRICA STENTS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA STENTS MARKET SIZE, BY NEUROVASCULAR STENTS, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA STENTS MARKET SIZE, BY PERIPHERAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA STENTS MARKET SIZE, BY UROLOGICAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA STENTS MARKET SIZE, BY METALLIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA STENTS MARKET SIZE, BY POLYMERIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA STENTS MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPE STENTS MARKET SIZE, BY NEUROVASCULAR STENTS, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPE STENTS MARKET SIZE, BY PERIPHERAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPE STENTS MARKET SIZE, BY UROLOGICAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPE STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPE STENTS MARKET SIZE, BY METALLIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPE STENTS MARKET SIZE, BY POLYMERIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPE STENTS MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPE STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPE STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 167. MIDDLE EAST STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 168. MIDDLE EAST STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. MIDDLE EAST STENTS MARKET SIZE, BY NEUROVASCULAR STENTS, 2018-2032 (USD MILLION)
  • TABLE 170. MIDDLE EAST STENTS MARKET SIZE, BY PERIPHERAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 171. MIDDLE EAST STENTS MARKET SIZE, BY UROLOGICAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 172. MIDDLE EAST STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 173. MIDDLE EAST STENTS MARKET SIZE, BY METALLIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 174. MIDDLE EAST STENTS MARKET SIZE, BY POLYMERIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 175. MIDDLE EAST STENTS MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 176. MIDDLE EAST STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 177. MIDDLE EAST STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 178. AFRICA STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 179. AFRICA STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 180. AFRICA STENTS MARKET SIZE, BY NEUROVASCULAR STENTS, 2018-2032 (USD MILLION)
  • TABLE 181. AFRICA STENTS MARKET SIZE, BY PERIPHERAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 182. AFRICA STENTS MARKET SIZE, BY UROLOGICAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 183. AFRICA STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 184. AFRICA STENTS MARKET SIZE, BY METALLIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 185. AFRICA STENTS MARKET SIZE, BY POLYMERIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 186. AFRICA STENTS MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 187. AFRICA STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 188. AFRICA STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 189. ASIA-PACIFIC STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 190. ASIA-PACIFIC STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 191. ASIA-PACIFIC STENTS MARKET SIZE, BY NEUROVASCULAR STENTS, 2018-2032 (USD MILLION)
  • TABLE 192. ASIA-PACIFIC STENTS MARKET SIZE, BY PERIPHERAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 193. ASIA-PACIFIC STENTS MARKET SIZE, BY UROLOGICAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 194. ASIA-PACIFIC STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 195. ASIA-PACIFIC STENTS MARKET SIZE, BY METALLIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 196. ASIA-PACIFIC STENTS MARKET SIZE, BY POLYMERIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 197. ASIA-PACIFIC STENTS MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 198. ASIA-PACIFIC STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 199. ASIA-PACIFIC STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 200. GLOBAL STENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 201. ASEAN STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 202. ASEAN STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 203. ASEAN STENTS MARKET SIZE, BY NEUROVASCULAR STENTS, 2018-2032 (USD MILLION)
  • TABLE 204. ASEAN STENTS MARKET SIZE, BY PERIPHERAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 205. ASEAN STENTS MARKET SIZE, BY UROLOGICAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 206. ASEAN STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 207. ASEAN STENTS MARKET SIZE, BY METALLIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 208. ASEAN STENTS MARKET SIZE, BY POLYMERIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 209. ASEAN STENTS MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 210. ASEAN STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 211. ASEAN STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 212. GCC STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 213. GCC STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 214. GCC STENTS MARKET SIZE, BY NEUROVASCULAR STENTS, 2018-2032 (USD MILLION)
  • TABLE 215. GCC STENTS MARKET SIZE, BY PERIPHERAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 216. GCC STENTS MARKET SIZE, BY UROLOGICAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 217. GCC STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 218. GCC STENTS MARKET SIZE, BY METALLIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 219. GCC STENTS MARKET SIZE, BY POLYMERIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 220. GCC STENTS MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 221. GCC STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 222. GCC STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 223. EUROPEAN UNION STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 224. EUROPEAN UNION STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 225. EUROPEAN UNION STENTS MARKET SIZE, BY NEUROVASCULAR STENTS, 2018-2032 (USD MILLION)
  • TABLE 226. EUROPEAN UNION STENTS MARKET SIZE, BY PERIPHERAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 227. EUROPEAN UNION STENTS MARKET SIZE, BY UROLOGICAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 228. EUROPEAN UNION STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 229. EUROPEAN UNION STENTS MARKET SIZE, BY METALLIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 230. EUROPEAN UNION STENTS MARKET SIZE, BY POLYMERIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 231. EUROPEAN UNION STENTS MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 232. EUROPEAN UNION STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 233. EUROPEAN UNION STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 234. BRICS STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 235. BRICS STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 236. BRICS STENTS MARKET SIZE, BY NEUROVASCULAR STENTS, 2018-2032 (USD MILLION)
  • TABLE 237. BRICS STENTS MARKET SIZE, BY PERIPHERAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 238. BRICS STENTS MARKET SIZE, BY UROLOGICAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 239. BRICS STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 240. BRICS STENTS MARKET SIZE, BY METALLIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 241. BRICS STENTS MARKET SIZE, BY POLYMERIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 242. BRICS STENTS MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 243. BRICS STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 244. BRICS STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 245. G7 STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 246. G7 STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 247. G7 STENTS MARKET SIZE, BY NEUROVASCULAR STENTS, 2018-2032 (USD MILLION)
  • TABLE 248. G7 STENTS MARKET SIZE, BY PERIPHERAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 249. G7 STENTS MARKET SIZE, BY UROLOGICAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 250. G7 STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 251. G7 STENTS MARKET SIZE, BY METALLIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 252. G7 STENTS MARKET SIZE, BY POLYMERIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 253. G7 STENTS MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 254. G7 STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 255. G7 STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 256. NATO STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 257. NATO STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 258. NATO STENTS MARKET SIZE, BY NEUROVASCULAR STENTS, 2018-2032 (USD MILLION)
  • TABLE 259. NATO STENTS MARKET SIZE, BY PERIPHERAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 260. NATO STENTS MARKET SIZE, BY UROLOGICAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 261. NATO STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 262. NATO STENTS MARKET SIZE, BY METALLIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 263. NATO STENTS MARKET SIZE, BY POLYMERIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 264. NATO STENTS MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 265. NATO STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 266. NATO STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 267. GLOBAL STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 268. UNITED STATES STENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 269. UNITED STATES STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 270. UNITED STATES STENTS MARKET SIZE, BY NEUROVASCULAR STENTS, 2018-2032 (USD MILLION)
  • TABLE 271. UNITED STATES STENTS MARKET SIZE, BY PERIPHERAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 272. UNITED STATES STENTS MARKET SIZE, BY UROLOGICAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 273. UNITED STATES STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 274. UNITED STATES STENTS MARKET SIZE, BY METALLIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 275. UNITED STATES STENTS MARKET SIZE, BY POLYMERIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 276. UNITED STATES STENTS MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 277. UNITED STATES STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 278. UNITED STATES STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 279. CHINA STENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 280. CHINA STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 281. CHINA STENTS MARKET SIZE, BY NEUROVASCULAR STENTS, 2018-2032 (USD MILLION)
  • TABLE 282. CHINA STENTS MARKET SIZE, BY PERIPHERAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 283. CHINA STENTS MARKET SIZE, BY UROLOGICAL STENTS, 2018-2032 (USD MILLION)
  • TABLE 284. CHINA STENTS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 285. CHINA STENTS MARKET SIZE, BY METALLIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 286. CHINA STENTS MARKET SIZE, BY POLYMERIC STENTS, 2018-2032 (USD MILLION)
  • TABLE 287. CHINA STENTS MARKET SIZE, BY MODE OF DELIVERY, 2018-2032 (USD MILLION)
  • TABLE 288. CHINA STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 289. CHINA STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)